<DOC>
	<DOC>NCT00683423</DOC>
	<brief_summary>The purpose of the study is to determine whether BMS-741672 improves neuropathic pain in diabetic patients.</brief_summary>
	<brief_title>BMS-741672 for Diabetic Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<criteria>Type 1 or 2 diabetics with painful, distal, symmetrical, sensorymotor neuropathy attributed to diabetes, of at least 12 months duration Screening HbA1c of ≥ 7% and ≤ 10% BMI ≤ 40 kg/m2 Patients with clinically significant, progressive, or potentially unstable disease of any body system including cardiovascular, gastrointestinal, central nervous system (CNS), psychiatric, endocrine (other than diabetes), tuberculosis or renal Women of childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>